Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. James A. Gilligan
WARNING LETTER
•James A. Gilligan•September 1, 2015

FDA WARNING_LETTER - James A. Gilligan - September 01, 2015

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore James A. Gilligan
Record Details

On August 25 and September 1, 2015, the FDA investigated Bellewood Farms' dairy operation in Woodville, New York. The investigation revealed multiple violations of the Federal Food, Drug, and Cosmetic Act.

A bob veal calf sold for slaughter on June 11, 2015, was found to have 9.1 ppm of neomycin residue in its kidney, exceeding the 7.2 ppm tolerance for cattle and having no acceptable level for veal calves, thus rendering the food adulterated under section 402(a)(2)(C)(ii). The farm also held animals under insanitary conditions, failing to maintain complete treatment records, which could lead to medicated animals with harmful drug residues entering the food supply, adulterating food under section 402(a)(4).

Furthermore, the farm engaged in extralabel use of several new animal drugs, including (b)(4) (neomycin sulfate and oxytetracycline hydrochloride), (b)(4) (ceftiofur sodium), (b)(4) (ampicillin), (b)(4) (flunixin meglumine), and (b)(4) (penicillin G procaine), without following approved labeling for animal class, dosage, indications for use, route of administration, or injection amount per site. These extralabel uses were not under the supervision of a licensed veterinarian, violating 21 C.F.R.

Company
James A. Gilligan
Inspection Date
September 1, 2015
Product Type
Drugs
Office
New York District Office
Person
  • Ronald M. Pace (Program Director)
Open in Dashboard

ID · 94f2c30f-3476-48a7-85cb-130e1cc2f5ec

Violation Codes10
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 530.11(a)21 CFR 530.11(b)21 CFR 530.11(c)21 CFR 530.41(a)(13)(ii)

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.